(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Paul Wahlgren, Managing Director of Skyler Brand Ventures, on luxury skin care and their patended neuropeptide technology used in a new concentrate for the face: XEP-30.
Bloomberg Intelligence
3,285 clip(s)
Intel Shares Fall on Report Nvidia Halts Production Test
Novo Nordisk Gets US Approval for Wegovy Obesity Pill
Larry Ellison’s Guarantee Ups Warner Bros. Stakes to a New Level